THE SCRIPPS RESEARCH INSTITUTE
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1924-12-11
- Employees
- 1K
- Market Cap
- -
- Website
- https://powermom.scripps.edu
Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis
- First Posted Date
- 2024-09-10
- Last Posted Date
- 2024-09-10
- Lead Sponsor
- Calibr, a division of Scripps Research
- Target Recruit Count
- 106
- Registration Number
- NCT06589219
- Locations
- 🇩🇪
Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hannover, Germany
Study to Assess PDM608 in Healthy Adult Subjects
- First Posted Date
- 2023-07-18
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Calibr, a division of Scripps Research
- Target Recruit Count
- 64
- Registration Number
- NCT05950906
- Locations
- 🇺🇸
Quotient Sciences-Miami, Inc, Miami, Florida, United States
Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T
- Conditions
- Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Small Lymphocytic Lymphoma (SLL)Relapsed/Refractory B-cell LymphomasPrimary Mediastinal Large B Cell LymphomaLymphoplasmacytic LymphomaBurkitt LymphomaDiffuse Large B-Cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Marginal Zone Lymphoma (MZL)
- Interventions
- First Posted Date
- 2020-07-28
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Calibr, a division of Scripps Research
- Target Recruit Count
- 36
- Registration Number
- NCT04488354
- Locations
- 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸Weill Cornell Medical College - New York Presbyterian Hospital, New York, New York, United States
🇺🇸Wake Forest Baptist Health, Winston-Salem, North Carolina, United States
Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo
- Conditions
- Interventions
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2023-02-03
- Lead Sponsor
- The Scripps Research Institute
- Target Recruit Count
- 50
- Registration Number
- NCT04466215
- Locations
- 🇺🇸
The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research, La Jolla, California, United States
CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies
- Conditions
- Interventions
- First Posted Date
- 2020-06-29
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Calibr, a division of Scripps Research
- Target Recruit Count
- 18
- Registration Number
- NCT04450069
- Locations
- 🇺🇸
University of California at San Diego, San Diego, California, United States
🇺🇸Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸Sarah Cannon Research Institute - Texas Transplant Institute, San Antonio, Texas, United States
Medication Development in Alcoholism: Suvorexant Versus Placebo
- Conditions
- Interventions
- First Posted Date
- 2020-01-14
- Last Posted Date
- 2023-04-26
- Lead Sponsor
- The Scripps Research Institute
- Target Recruit Count
- 26
- Registration Number
- NCT04229095
- Locations
- 🇺🇸
Scripps Research, La Jolla, California, United States
MAP4343 Treatment for Alcohol Use Disorder
- Conditions
- Interventions
- First Posted Date
- 2019-11-08
- Last Posted Date
- 2022-03-11
- Lead Sponsor
- The Scripps Research Institute
- Registration Number
- NCT04157114
- Locations
- 🇺🇸
The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research, La Jolla, California, United States
First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2019-09-04
- Last Posted Date
- 2023-05-12
- Lead Sponsor
- Calibr, a division of Scripps Research
- Target Recruit Count
- 22
- Registration Number
- NCT04077021
- Locations
- 🇺🇸
Johns Hopkins University - Sydney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
🇺🇸Medical College of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸Karmanos Cancer Institute, Detroit, Michigan, United States
Medication Development in Alcoholism: Apremilast Versus Placebo
- First Posted Date
- 2017-06-05
- Last Posted Date
- 2022-09-16
- Lead Sponsor
- The Scripps Research Institute
- Target Recruit Count
- 51
- Registration Number
- NCT03175549
- Locations
- 🇺🇸
The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research, La Jolla, California, United States
A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2022-12-27
- Lead Sponsor
- Calibr, a division of Scripps Research
- Target Recruit Count
- 60
- Registration Number
- NCT03133676
- Locations
- 🇺🇸
Clinical Research of West Florida, Clearwater, Florida, United States
🇺🇸Diablo Clinical Research, Walnut Creek, California, United States
🇺🇸Altoona Center for Clinical Research, Duncansville, Pennsylvania, United States